Evidence map›Paper›PMID 38659858›Full record

ArticlebioRxiv : the preprint server for biology2024

Loss of circulating CD8α

Nezar Mehanna, Atul Pradhan, Rimanpreet Kaur, Theodota Kontopoulos, Barbara Rosati, David Carlson, Nai-Kong Cheung, Hong Xu, James Bean, Katherine Hsu and 2 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Nezar MehannaRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.
Atul PradhanRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.
Rimanpreet KaurRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.
Theodota KontopoulosSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Barbara RosatiRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.
David CarlsonRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.
Nai-Kong CheungSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.ORCID 0000-0001-6323-5171
Hong XuSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
James BeanSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Katherine HsuSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Jean-Benoit Le LuduecSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Charles Kyriakos VorkasRenaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794.ORCID 0000-0003-4952-7041
Memorial Sloan Kettering Cancer Center · USRenaissance University · NG

Funding

T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
The role of Mucosal-associated invariant T (MAIT) cells during the innate immune response to Mycobacterium tuberculosisK08AI132739 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI VORKAS, CHARLES KYRIAKOS · 2018 to 2022
$921k
Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.R21AI171578 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI VORKAS, CHARLES KYRIAKOS · 2023 to 2024
$468k
Riboflavin biosynthesis and utilization in Mycobacterium tuberculosisR21AI183259 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SEELIGER, JESSICA CHUANG · 2024 to 2025
$433k
NIAID NIH HHS K08 AI132739NIAID NIH HHS R21 AI171578NIAID NIH HHS R21 AI183259NIAID NIH HHS T32 AI007613
6 · The paper itself

Abstract

Natural Killer (NK) cells can recognize and kill

Identifiers

PMID38659858
PMCPMC11042275
OpenAlexW4394989183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.